BSE: 524506 - Coral Laboratories Limited

Rentabilität für sechs Monate: -19.84%
Dividendenrendite: +0.23%

Aktionsplan Coral Laboratories Limited


Über das Unternehmen Coral Laboratories Limited

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally.

weitere details
The company offers antibiotics/antibacterial products, including antifungal, antiemetic, analgesics/antipyretic/antiinflammatory, antispasmodic, anticold, antiallergic, antiasthmatic, antidiabetic, antiemetics, anthelmentic, thyroid, and antiprotozoal/antiamebic products; antimalarial drugs, antipsychotic drugs, gastro-intestinal drugs, kits, muscle relaxants, cough suppressant/expectorant products, cardiovascular medicines, oral antiseptic preparations, mouthwashes, calcium preparations, and appetizers; and nutritional, protein, and iron supplements, as well as other products. It also provides cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. It provides its products in various dosage forms, including tablets, capsules, low RH facilities, liquid orals, liquids and powders, dry syrups, drops, ointment and creams, gels and lotions, granules powders, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.23
Дивиденд ао 2
Сайт http://corallab.com
Цена ао 757.6
Preisänderung pro Tag: -2.54% (747.35)
Preisänderung pro Woche: -1.55% (739.8)
Preisänderung pro Monat: -9.81% (807.6)
Preisänderung über 3 Monate: -4.44% (762.2)
Preisänderung über sechs Monate: -19.84% (908.6)
Preisänderung pro Jahr: +93.76% (375.9)
Preisänderung über 3 Jahre: +114.98% (338.8)
Preisänderung über 5 Jahre: +432.03% (136.9)
Preisänderung seit Jahresbeginn: -0.7562% (733.9)

Unterschätzung

Name Bedeutung Grad
P/S 1.72 8
P/BV 0.7979 9
P/E 8.97 9
EV/EBITDA 0 0
Gesamt: 8

Effizienz

Name Bedeutung Grad
ROA, % 8.31 3
ROE, % 9.5 3
Gesamt: 2

Dividenden

Name Bedeutung Grad
Div yield, % 0.23 0.58
DSI 0.9286 9.29
Gesamt: 1.91

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 16.32 3
Rentabilität Ebitda, % 0 5
Rentabilität EPS, % 121.44 10
Gesamt: 7.6

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Girish Madanlal Dhameja Whole-Time Director 1981 (44 Jahr)
Ms. Sushma Shashi Kadkade CFO & Non-Exec. Director 1976 (49 Jahre)
Ms. Ruchi Anjaria Company Sec. & Compliance Officer
Mr. Kapil K. Shah Exec. Officer

Adresse: India, Mumbai, #3B Patanwala Industrial Estate - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: http://corallab.com